MAGNESIA PHOSPHORICA
NDC 15631-0282, MAGNESIA PHOSPHORICA, pellet, from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.
- Product NDC
- 15631-0282
- Status
- Listed
- Labeler
- Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15631-0282 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE1 [hp_X]/1
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15631-0282-0 | 15631028200 | 100 PELLET in 1 PACKAGE (15631-0282-0) |
| 15631-0282-1 | 15631028201 | 200 PELLET in 1 PACKAGE (15631-0282-1) |
| 15631-0282-2 | 15631028202 | 400 PELLET in 1 PACKAGE (15631-0282-2) |
| 15631-0282-3 | 15631028203 | 750 PELLET in 1 PACKAGE (15631-0282-3) |
| 15631-0282-4 | 15631028204 | 2500 PELLET in 1 PACKAGE (15631-0282-4) |
| 15631-0282-5 | 15631028205 | 12500 PELLET in 1 PACKAGE (15631-0282-5) |
| 15631-0282-6 | 15631028206 | 500 PELLET in 1 PACKAGE (15631-0282-6) |
| 15631-0282-7 | 15631028207 | 1000 PELLET in 1 PACKAGE (15631-0282-7) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 15631-0282 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15631-0282 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15631-0282. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.